IndustryPayments

NIMISH NAIK

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology WEXFORD, PA NPI 1508910159

Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology PA AKEBIA THERAPEUTICS INC All categories

General Payments — all program years on this page

$81,078.82

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 344
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $7,209.57 across 71 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $4,300.001
Food and Beverage $1,470.3864
Travel and Lodging $1,430.975
Education $8.221

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
AKEBIA THERAPEUTICS INC $6,139.6119
Amgen Inc. $472.2914
Retrophin, Inc. $190.3416
Bayer HealthCare Pharmaceuticals Inc. $55.923
Relypsa, Inc. $55.063
Fresenius USA Marketing, Inc. $54.673
Acerta Pharma LLC $52.693
CALLIDITAS THERAPEUTICS US INC. $37.622
Otsuka America Pharmaceutical, Inc. $37.052
Otsuka Pharmaceutical Development & Commercialization, Inc. $35.372
Lilly USA, LLC $23.061
Aurinia Pharma U.S., Inc. $21.391
Mallinckrodt Hospital Products Inc. $20.811
Boehringer Ingelheim Pharmaceuticals, Inc. $13.691

By program year

Program yearAmountRecords
2018 $22,572.2651
2019 $16,585.8152
2020 $2,486.5812
2021 $6,183.5634
2022 $14,524.0652
2023 $11,516.9872
2024 $7,209.5771

Records — PY2024 (71)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086232970 Bayer Healthcare Pharmaceuticals Inc. $20.77 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086245842 Bayer Healthcare Pharmaceuticals Inc. $18.33 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086255436 Bayer Healthcare Pharmaceuticals Inc. $16.82 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104349046 AstraZeneca Pharmaceuticals LP $16.18 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104468058 AstraZeneca Pharmaceuticals LP $16.26 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104542740 AstraZeneca Pharmaceuticals LP $20.25 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957548 Amgen Inc. $52.43 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957558 Amgen Inc. $23.08 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957564 Amgen Inc. $26.23 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957569 Amgen Inc. $9.41 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957577 Amgen Inc. $124.77 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957583 Amgen Inc. $137.53 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957588 Amgen Inc. $9.66 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957595 Amgen Inc. $8.89 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957601 Amgen Inc. $12.06 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957609 Amgen Inc. $7.65 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957615 Amgen Inc. $13.20 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957628 Amgen Inc. $17.14 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115957637 Amgen Inc. $7.54 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117637713 Amgen Inc. $22.70 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039346 Boehringer Ingelheim Pharmaceuticals, Inc. $13.69 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118838577 Otsuka Pharmaceutical Development & Commercialization, Inc. $15.47 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118838579 Otsuka Pharmaceutical Development & Commercialization, Inc. $19.90 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118948322 Otsuka America Pharmaceutical, Inc. $15.09 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118948324 Otsuka America Pharmaceutical, Inc. $21.96 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124037638 Vifor Pharma, Inc. $17.79 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124039176 Vifor Pharma, Inc. $22.30 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124060806 Vifor Pharma, Inc. $14.97 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135291009 Lilly USA, LLC $23.06 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141507862 CALLIDITAS THERAPEUTICS US INC. $22.89 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141511255 CALLIDITAS THERAPEUTICS US INC. $14.73 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145111757 Mallinckrodt Hospital Products Inc. $20.81 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145825937 AKEBIA THERAPEUTICS INC $10.17 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145825939 AKEBIA THERAPEUTICS INC $28.30 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145827188 AKEBIA THERAPEUTICS INC $19.65 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145829076 AKEBIA THERAPEUTICS INC $18.49 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145829078 AKEBIA THERAPEUTICS INC $3.73 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145829680 AKEBIA THERAPEUTICS INC $19.97 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145830983 AKEBIA THERAPEUTICS INC $19.27 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145831371 AKEBIA THERAPEUTICS INC $17.60 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145832149 AKEBIA THERAPEUTICS INC $4,300.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1145832167 AKEBIA THERAPEUTICS INC $344.60 11/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1145832183 AKEBIA THERAPEUTICS INC $110.00 11/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1145832197 AKEBIA THERAPEUTICS INC $801.95 11/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1145832215 AKEBIA THERAPEUTICS INC $47.08 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145832233 AKEBIA THERAPEUTICS INC $20.91 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145832251 AKEBIA THERAPEUTICS INC $67.04 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145832263 AKEBIA THERAPEUTICS INC $90.00 11/16/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1145832283 AKEBIA THERAPEUTICS INC $84.42 11/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1145832285 AKEBIA THERAPEUTICS INC $128.21 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145834145 AKEBIA THERAPEUTICS INC $8.22 10/30/2024 Education Undisputed 01/23/2026 View at CMS
1149901992 Travere Therapeutics, Inc. $2.91 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149901996 Travere Therapeutics, Inc. $3.76 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902000 Travere Therapeutics, Inc. $3.80 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902004 Travere Therapeutics, Inc. $4.86 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902008 Travere Therapeutics, Inc. $4.97 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902012 Travere Therapeutics, Inc. $5.25 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902016 Travere Therapeutics, Inc. $6.80 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902020 Travere Therapeutics, Inc. $7.24 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902024 Travere Therapeutics, Inc. $11.83 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902028 Travere Therapeutics, Inc. $14.88 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902032 Travere Therapeutics, Inc. $15.06 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902036 Travere Therapeutics, Inc. $16.13 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902040 Travere Therapeutics, Inc. $21.18 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902044 Travere Therapeutics, Inc. $21.92 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902048 Travere Therapeutics, Inc. $23.54 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149902052 Travere Therapeutics, Inc. $26.21 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150688205 Aurinia Pharma U.S., Inc. $21.39 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154210560 Fresenius USA Marketing, Inc. $13.95 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154210562 Fresenius USA Marketing, Inc. $20.27 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154210564 Fresenius USA Marketing, Inc. $20.45 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.